Attached files
file | filename |
---|---|
EX-31.1 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10k2015ex31i_amarantusbio.htm |
EX-31.2 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10k2015ex31ii_amarantusbio.htm |
EX-32.1 - CERTIFICATION - Amarantus Bioscience Holdings, Inc. | f10k2015ex32i_amarantusbio.htm |
EX-21.1 - LIST OF SUBSIDIARIES - Amarantus Bioscience Holdings, Inc. | f10k2015ex21i_amarantusbio.htm |
EX-23.1 - CONSENT OF MARCUM LLP - Amarantus Bioscience Holdings, Inc. | f10k2015ex23i_amarantusbio.htm |
10-K - ANNUAL REPORT - Amarantus Bioscience Holdings, Inc. | f10k2015_amarantusbioscience.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this annual report of Amarantus BioScience Holdings, Inc. (the “Registrant”) on Form 10-K for the period ended December 31, 2015, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the date indicated below, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(a) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(b) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
Date: May 16, 2016 | /s/ Robert Farrell |
Robert Farrell | |
Chief Financial Officer (Principal Financial Officer) |